News

Solar geoengineering has been proposed as one way to combat global warming, but a new study suggests it could have a negative impact on the protein levels of key crops.

Researchers genetically engineered stomach organoids to transform them into pancreatic beta cells capable of secreting insulin.

New insights into kidney function tests suggest using creatinine and cystatin C together may lower the risk of kidney failure.

New research has linked the loss of perineuronal nets in the brain to the loss of the ability to recognize loved ones, identifying a new drug target.

Bacteria can spread by sugar-driven “swashing” or by gear-controlled gliding, redefining how microbes colonize surfaces and cause infection.

New research has found that commonly used heartburn and blood pressure medications may interact with cancer therapies, influencing side effects and survival outcomes.

Scientists have used their discovery of previously unknown mechanisms in an anti-inflammatory pathway to develop a powerful upgrade: an engineered antibody that delivers the effectiveness of IVIG at fraction of the dose in mice.

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is notoriously aggressive and lacks effective treatments.

Researchers at Science Tokyo have created a lab-grown liver organoid that mimics regeneration and scarring, offering a new platform to study fibrosis and test therapies that could reverse chronic liver damage.

Researchers from the University of Rochester and Harvard Medical School developed a nano-micelle CBD formulation that rapidly reached the brain and relieved neuropathic pain in mice. The approach improved CBD delivery across the blood–brain barrier.